Antiphospholipid Syndrome (APS), first described in 1980 by Graham Hughes as Cardiolipin Syndrome, represents the most common form of acquired thrombophilia, associated with the presence of antiphospholipid antibodies (aPL) in patients’ serum [1]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.